Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines
- PMID: 1940938
- PMCID: PMC1014470
- DOI: 10.1136/jnnp.54.8.683
Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines
Abstract
Serial gadolinium enhanced MRI of the brain detects much clinically silent disease activity in early relapsing-remitting and secondary progressive multiple sclerosis (MS), and thus has an important role in monitoring the effects of therapy. Based on the proceedings of a recent Commission of the European Communities (CEC) workshop and a review of the literature, guidelines are presented for using MRI to monitor treatment trials in MS. The guidelines consider: A) MRI system and techniques; B) patient selection; C) trial design; D) analysis of results. Priorities for future research are also indicated.
Comment in
-
MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):978. doi: 10.1136/jnnp.55.10.978. J Neurol Neurosurg Psychiatry. 1992. PMID: 1431970 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical